ABBV-744 is a first-in-class, orally active and selective inhibitor of the BDII domain of the BET family of proteins with IC50 values of 4-18 nM for BRD2, BRD3, BRD4, and BRDT for AML and metastatic desmoplasia-resistant prostate cancer.
Molecular Weight:
491.55
Purity:
>99%
CAS Number:
[2138861-99-9]
Formula:
C28H30FN3O4
Target:
Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted